RP
Radhika Pradhan
About Radhika Pradhan
Data last updated:
Radhika Pradhan has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Jeevak Heart Hospital And Reaserch Institute Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Jeevak Heart Hospital And Reaserch Institute Private Limited at ₹19.79 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Dec 2022 | 1994 | ₹19.79 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Radhika Pradhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Radhika Pradhan
Radhika Pradhan has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Jeevak Heart Hospital And Reaserch Institute Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Jeevak Heart Hospital And Reaserch Institute Private Limited at ₹19.79 Cr (FY 2025).
Radhika Pradhan is associated with 1 company as Director, including Jeevak Heart Hospital And Reaserch Institute Private Limited (₹19.79 Cr).
Radhika Pradhan has expertise in General Business.
Radhika Pradhan has 3 years in corporate governance.
By reported revenue, the largest current company of Radhika Pradhan is Jeevak Heart Hospital And Reaserch Institute Private Limited, with revenue of ₹19.79 Cr (FY 2025).
Radhika Pradhan currently holds positions at 1 company: Jeevak Heart Hospital And Reaserch Institute Private Limited (₹19.79 Cr).